Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen From Insider Profile
4 Followers
Stephen From, EC, Director at Kiora Pharmaceuticals, holds 67.69K shares in Kiora Pharmaceuticals (Ticker: KPRX).
Stephen From Kiora Pharmaceuticals (KPRX)EC, Director
Kiora Pharmaceuticals (KPRX)
EC, Director
Ranked #87,085 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-37.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
EC, Director
Roles that Stephen From holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 16, 2016 - Sep 16, 2017
Return:-16.40%
The most profitable trade made by Stephen From
Stephen From's Trading History
List of latest transactions for each holding click on a transaction to see Stephen From's performance on stock
You May Also Like
Stephen From insider profile FAQ
What is the percentage of profitable transactions made by Stephen From?
The percentage of profitable transactions made by Stephen From is 0%.
What is the average return per transaction made by Stephen From?
The average return per transaction made by Stephen From is -37.90%.
What stocks does Stephen From hold?
Stephen From holds: KPRX stocks.
What was Stephen From’s latest transaction?
Stephen From latest transaction was an Uninformative Sell of $352.08.
What was Stephen From's most profitable transaction?
Stephen From’s most profitable transaction was an Informative Buy of KPRX stock on September 16, 2016. The return on the trade was -16.40%.
What is Stephen From's role in Kiora Pharmaceuticals?
Stephen From's role in Kiora Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.